Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap371.49B
Enterprise Value429.44B
Trailing P/E102.68
Forward P/E117.86
ABBV
(NYSE)AbbVie Inc.
$213.76-- (--)
Loading... - Market loading
AbbVie (ABBV) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)5.94
Forward Price/Sales5.43
Price/Book (mrq)-115.62
Price/FCF (ttm)20.95
Price/OCF (ttm)19.61
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue6.84
EV/Earnings118.14
EV/EBITDA21.19
EV/EBIT31.30
EV/FCF24.10
Stock Price
Current price, 52-week range, and moving averages
Current Price$213.76
1-Day Change-0.47%
52-Week High$244.81
52-Week Low$176.57
52-Week Change6.69%
YTD Change-8.68%
1-Year Change12.76%
50-Day MA$211.21
200-Day MA$218.48
Avg Volume (30 day)6.50M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding1.77B
Book Value per Share$-1.82
Net Cash per Share$-31.69
FCF per Share$10.04
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$258.06
Target Upside/Downside20.72%
Analyst ConsensusBuy
Analyst Count20
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin70.68%
EBITDA Margin (ttm)32.27%
EBIT Margin (ttm)21.84%
Operating Margin (ttm)26.42%
Pretax Margin (ttm)9.51%
Profit Margin (ttm)5.79%
FCF Margin (ttm)28.36%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Assets (ttm)2.71%
Return on Invested Capital (ttm)15.75%
Return on Capital Employed (ttm)15.13%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue62.82B
Gross Profit44.40B
Operating Income16.60B
Pretax Income5.97B
Net Income3.63B
EBITDA20.27B
EBIT13.72B
Diluted EPS$2.05
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow19.03B
Capital Expenditures1.21B
Free Cash Flow17.82B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth9.50%
Dividend Growth5.64%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)133.96B
Cash & Securities (mrq)5.23B
Net Cash (mrq)-56.21B
Net Cash per Share$-31.69
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)61.44B
Working Capital (mrq)-14.23B
Total Equity (mrq)-3.23B
Book Value per Share$-1.82
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)0.67
Quick Ratio (mrq)0.56
Debt/EBITDA (ttm)3.03
Debt/FCF (ttm)3.45
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$6.74
Dividend Yield3.22%
Payout Ratio (Earnings)200.00%
Payout Ratio (FCF)67.11%
Dividend Growth (YoY)5.64%
Years of Dividend Growth12
Ex-Dividend DateApr 15, 2026
Pay DateMay 15, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield0.97%
FCF Yield4.77%
Buyback Yield0.23%
Total Shareholder Yield3.45%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score2.15
Piotroski F-Score7/9
Dividend Score61.94
Frequently Asked Questions About AbbVie Statistics
What are the key financial metrics for ABBV?
AbbVie Inc. (ABBV) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is ABBV's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether AbbVie is overvalued or undervalued.
How do I read ABBV's profitability ratios?
AbbVie's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do ABBV's debt ratios indicate?
The financial health section shows AbbVie's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is ABBV's dividend analysis?
The dividend section covers AbbVie's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.